Cell cycle regulatory proteins and apoptosis in B-cell chronic lymphocytic leukemia

Haematologica

Volumn 86, Issue 12, 2001, Pages 1296-1304

  Wolowiec, D ^a   Ciszak, L ^a   Kosmaczewska, A ^a   Bocko, D ^a   Teodorowska, R ^a   Frydecka, I ^a   Kuliczkowski, K ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Apoptosis; Cell proliferation; Chronic lymphocytic leukemia; Cyclins D; p27Kip1

Indexed keywords

CD19 ANTIGEN; CD5 ANTIGEN; CELL CYCLE PROTEIN; CYCLIN D; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P27; REGULATOR PROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; PERIPHERAL LYMPHOCYTE; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CHILD; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MIDDLE AGED; TUMOR SUPPRESSOR PROTEINS;

EID: 0035666115     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Chronic lymphocytic leukemia
2. 0
3. Mechanisms of cyclin-dependent kinase regulation: Structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors
4. RB kinases and RB-binding proteins: New points of view
5. The retinoblastoma protein and cell cycle control
6. The E2F transcription factors: Key regulators of cell proliferation
7. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes
8. Expression of cyclins A, D2 and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry
9. Cell-cycle inhibitors: Three families united by a common cause
10. Overexpression of cyclin D2 in chronic B-cell malignancies
11. Gene expression in chronic lymphocytic leukemia B cells and changes during induction of apoptosis
12. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue
13. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer
14. Kip1 in chronic B-cell lymphocytic leukemia
15. Selective usage of D-type cyclins in lymphoid malignancies
16. Kip1-cyclin D3 colocalization in tumor cells
17. Demonstration of cytoplasmic and nuclear antigens in acute leukaemia using flow cytometry
18. Monoclonal antibodies reactive with the T cell receptor ζ chain: Production and characterization using a new method
19. Expression of signal-transducing ζ chain in peripheral blood T cells and natural killer cells in patients with Hodgkin's disease in different phases of the disease
20. Kip1 overexpression causes apoptotic death of mammalian cells
21. Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27
22. Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells
23. Kip1 mediates its anti-apoptotic activity
24. Kip1)
25. Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repair
26. Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications
27. Kip1
28. Kip1 on resistance of tumor cells to anticancer agents
29. Amplification of cyclin genes in colorectal carcinomas
30. Molecular characterization of p12 abnormalities in hematologic malignancies: Deletion of KIP1, rearrangement of TEL, and amplification of CCND2
31. High-level DNA amplifications are common genetic aberrations in B-cell neoplasms
32. Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes
33. A pivotal role of cyclin D3 and cyclin-dependent kinase inhibitor p27 in the regulation of IL-2-, IL-4-, or IL-10-mediated human B cell proliferation
34. Expression of cyclin D2 and D3 in lymphoid lesions